COVID-19 patient credits recovery to drug developed by Vancouver biotech company |   #CytoDyn $CYDY #Leronlimab #Biotechnology #investments #Biotech #coronavirus #Covid19 #stocks #Pharmaceuticals #FDA #clinicaltrials #CoronavirusUSA